Publication:
Clinicians’ preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force

dc.contributor.authorHidalgo‑Mazzei, Diego
dc.contributor.authorMantingh, Tim
dc.contributor.authorPérez de Mendiola, Xavier
dc.contributor.authorSamalin, Ludovic
dc.contributor.authorUndurraga, Juan
dc.contributor.authorStrejilevich, Sergio
dc.contributor.authorSeverus, Emanuel
dc.contributor.authorBauer, Michael
dc.contributor.authorGonzález-Pinto, Ana
dc.contributor.authorNolen, Willem A.
dc.contributor.authorYoung, Allan H.
dc.contributor.authorVieta, Eduard
dc.date.accessioned2024-06-04T20:17:33Z
dc.date.available2024-06-04T20:17:33Z
dc.date.issued2023
dc.description.abstractBackground Lithium has long been considered the gold‑standard pharmacological treatment for the maintenance treatment of bipolar disorders (BD) which is supported by a wide body of evidence. Prior research has shown a steady decline in lithium prescriptions during the last two decades. We aim to identify potential factors explaining this decline across the world with an anonymous worldwide survey developed by the International Society for Bipolar Disorders (ISBD) Task Force “Role of Lithium in Bipolar Disorders” and distributed by diverse academic and professional international channels. Results A total of 886 responses were received of which 606 completed the entire questionnaire while 206 completed it partially. Respondents were from 43 different countries comprising all continents. Lithium was the most preferred treatment option for the maintenance of BD patients (59%). The most relevant clinical circumstances in which lithium was the preferred option were in patients with BD I (53%), a family history of response (18%), and a prior response during acute treatment (17%). In contrast, Lithium was not the preferred option in case of patients´ negative beliefs and/or attitudes towards lithium (13%), acute side‑effects or tolerability problems (10%) and intoxication risk (8%). Clinicians were less likely to prefer lithium as a first option in BD maintenance phase when practising in developing economy countries [X2 (1, N = 430) = 9465, p = 0.002) ] and private sectors [X2 (1, N = 434) = 8191, p = 0.004)]. Conclusions Clinicians’ preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders appear to be affected by both the patients’ beliefs and the professional contexts where clinicians provide their services. More research involving patients is needed for identifying their attitudes toward lithium and factors affecting its use, particularly in developing economies.
dc.description.versionVersión publicada
dc.format.extent9 p.
dc.identifier.citationHidalgo-Mazzei, D., Mantingh, T., Pérez de Mendiola, X. et al. Clinicians’ preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force. Int J Bipolar Disord 11, 20 (2023). https://doi.org/10.1186/s40345-023-00301-y
dc.identifier.doihttps://doi.org/10.1186/s40345-023-00301-y
dc.identifier.urihttps://hdl.handle.net/11447/9027
dc.language.isoen
dc.rightsAtribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/cl/
dc.subjectLithium
dc.subjectBipolar disorders
dc.subjectTreatment
dc.subjectMaintenance
dc.subjectSurvey
dc.subjectUse
dc.subjectPreferences
dc.subjectAttitudes
dc.titleClinicians’ preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force
dc.typeArticle
dcterms.accessRightsAcceso abierto
dcterms.sourceInternational Journal of Bipolar Disorders
dspace.entity.typePublication
relation.isAuthorOfPublication7a9f060d-7506-44d2-84ae-30bce0fea90a
relation.isAuthorOfPublication.latestForDiscovery7a9f060d-7506-44d2-84ae-30bce0fea90a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
s40345-023-00301-y.pdf
Size:
802.53 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description: